Pneumoconiosis Treatment and Prevention

Pneumoconiosis treatment and prevention are of significant concern for many individuals, especially those whose occupation puts them at a particularly high risk for contracting some form of this lung disease. Pneumoconiosis is a general term that can be collectively applied to lung diseases that result from inhaling particles of mineral dust, including black lung disease (caused by inhaling coal mine dust), siderosis (caused by inhaling iron dust) and silicosis (caused by inhaling silica dust). Individuals who have a high risk of developing pneumoconiosis include miners, construction workers and manufacturers, among many others.

Because pneumoconiosis gradually develops over the course of several years, early prevention and detection are key to avoiding treatment later in life. If your job requires you to be around coal mine dust, iron dust, silica dust or any other mineral dust, you should take the following steps to minimize your chances of developing pneumoconiosis:

  • Ensure proper ventilation — If you have any concerns about how your workplace is ventilated, you should voice them to your supervisor as soon as possible.
  • Wear proper attire — At the very least, be sure to wear a face mask while at work. Also make sure that your protective garments fit properly.
  • Wash your skin — Make sure to thoroughly wash any part of your body that comes into contact with mineral dust. Be particularly careful to wash your face and hands before eating or drinking. You should also remove dust from your work attire.
  • Quit smoking — Although smoking itself does not cause pneumoconiosis, it does increase your risk of developing the condition, so you should stop smoking as soon as possible.
  • Attend regular checkups — Because early detection may help to minimize any resulting damage, you should attend regular physicals and undergo routine chest X-rays. Once you’ve acquainted yourself with the common symptoms of pneumoconiosis, be sure to monitor yourself and report any concerns to your doctor as soon as possible.

If you’ve already contracted some form of pneumoconiosis, the Lung Institute offers treatment through our innovative stem cell therapy procedures. Unlike some other treatment options that only address the symptoms of pneumoconiosis, stem cell therapy may also slow the disease’s progression.

If you’ve developed pneumoconiosis in spite of the attempted prevention techniques and traditional treatment has not provided adequate symptom relief, please call the Lung Institute today at (800) 729-3065 to discuss the benefits of our innovative stem cell treatment options.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.